Seeking Alpha

Genzyme's (GENZ +0.2%) board unanimously recommends its shareholders accept a $20.1B takeover...

Genzyme's (GENZ +0.2%) board unanimously recommends its shareholders accept a $20.1B takeover offer from Sanofi-Aventis (SNY -0.3%). Earlier, Sanofi extended its offer (the second-largest biotech deal ever) to April 1. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|